Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialLaura Guay, J. Brooks Jackson, Mark Mirochnick et al.|The Lancet|1999Cited by 1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialJ. Brooks Jackson, Francis Mmiro, Philippa Musoke et al.|The Lancet|2003Cited by 525
Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of LifeMark Mirochnick, Lynne Mofenson, Taha E. Taha et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013Cited by 67
Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 MonthsAvinash K. Shetty, Mary T. Bassett, Hoosen Coovadia et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2003Cited by 64
Breast‐Milk Shedding of Drug‐Resistant HIV‐1 Subtype C in Women Exposed to Single‐Dose NevirapineEsther J. Lee, Rami Kantor, Lynn S. Zijenah et al.|The Journal of Infectious Diseases|2005Cited by 62